AzTrials
AzTrials

Colonrectal CancerNCT07876388

Compassion-Based Rehabilitation Needs Assessment Following Colorectal Cancer Surgery

A study testing Compassionate Access Targeted Therapy in people with Colonrectal Cancer and Colonrectal Cancer (CRC), run by Esbjerg Hospital - University Hospital of Southern Denmark at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial evaluated the effect of a compassion-based intervention compared with standard procedure for rehabilitation needs assessment among patients undergoing surgery for colorectal cancer with curative intent. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colonrectal Cancer, Colonrectal Cancer (CRC)
What is being tested?
Compassionate Access Targeted Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
77 participants
Where
1 siteDenmark
Study dates
10 Oct 2023to 4 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older.
  • Patients undergoing surgery with curative intent for colorectal cancer (colon or rectal cancer).
  • Able to speak and understand Danish.

Who cannot join

  • Patients younger than 18 years.
  • Patients unable to speak or understand Danish.
  • Patients not undergoing surgery with curative intent for colorectal cancer.
  • -

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Esbjerg Sygehus

    Esbjerg, 6700

Other trials in Denmark

About this study

Official title: Compassion Intervention Versus Standard Procedure in Rehabilitation Needs Assessment Following Colorectal Cancer Surgery: A Randomized Controlled Trial

This randomized controlled trial evaluated the effect of a compassion-based intervention compared with standard procedure for rehabilitation needs assessment among patients undergoing surgery for colorectal cancer with curative intent.

Participants were randomly assigned to either a structured, compassion-supported rehabilitation needs assessment or standard postoperative care. The intervention focused on identifying physical, psychological, and social rehabilitation needs through compassionate communication and facilitating referral to municipal cancer rehabilitation services.

The primary outcome was health-related quality of life measured using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) at three months. Secondary outcomes included anxiety, depression, self-compassion, and participation in cancer rehabilitation.

Being tested
Compassionate Access Targeted Therapy
Keywords
colonrectal cancer, compassion, randomized controlled trial, Patient-centered care, Cancer rehabilitation, Needs assessment

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Compassionate Access Targeted TherapyBehavioural

    The intervention consisted of a structured, compassion-supported rehabilitation needs assessment delivered during an approximately 30-minute face-to-face consultation with a registered nurse trained in compassion-based approaches. The consultation took place approximately seven days after the standard postoperative follow-up visit.

    The intervention incorporated three components: (1) systematic identification of physical, psychological, and social rehabilitation needs using the standard needs assessment framework; (2) compassion-supported communication characterized by attentive listening, presence, openness, non-judgment, and sensitivity to patients' concerns; and (3) shared decision-making regarding referral to municipal cancer rehabilitation services.

    When rehabilitation needs were identified and the patient agreed, referral to municipal cancer rehabilitation was facilitated according to standard hospital procedures.

Study groups in NCT07876388
Study groupRoleWhat they receive
Standard ProcedureNo interventionParticipants allocated to the control group received standard postoperative care following colorectal cancer surgery. Approximately two weeks after surgery, patients attended an outpatient follow-up consultation with a physician and a colorectal nurse. Subsequently, a nurse from the outpatient clinic conducted a telephone follow-up during which rehabilitation needs could be assessed using the standard needs assessment checklist. Patients with identified rehabilitation needs could be referred to municipal cancer rehabilitation services according to routine clinical procedures. No additional compassion-supported consultation was provided.
Compassion interventionExperimentalParticipants allocated to the intervention group received standard postoperative care followed by an additional structured, compassion-supported rehabilitation needs assessment approximately seven days after the standard postoperative follow-up. The intervention consisted of an approximately 30-minute face-to-face consultation conducted by a registered nurse trained in compassion-based approaches. The consultation focused on identifying physical, psychological, and social rehabilitation needs through compassionate communication, attentive listening, and non-judgmental dialogue. Identified needs were discussed with the patient, and referral to municipal cancer rehabilitation services was facilitated through shared decision-making when appropriate.
Receives: Behavioral: Compassionate Access Targeted Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Health-Related Quality of Life Measured by FACT-C Total Score

    Health-related quality of life will be assessed using the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) questionnaire. The FACT-C measures physical, social, emotional, and functional well-being, as well as colorectal cancer-specific concerns. The total score ranges from 0 to 136, with higher scores indicating better health-related quality of life. The primary outcome is the between-group difference in FACT-C total score at the three-month follow-up.

    Measured: 3 months after the intervention

Secondary outcomes (4)
  1. Anxiety Severity Measured by m-ESAS

    Anxiety will be assessed using the anxiety item from the Modified Edmonton Symptom Assessment System (m-ESAS). Scores range from 0 to 10, with higher scores indicating greater anxiety severity. Scores will be compared between the intervention and standard procedure groups.

    Measured: Baseline, 1 month, and 3 months

  2. Depression Severity Measured by m-ESAS

    Depression will be assessed using the depression item from the Modified Edmonton Symptom Assessment System (m-ESAS). Scores range from 0 to 10, with higher scores indicating greater depression severity. Scores will be compared between the intervention and standard procedure groups.

    Measured: Baseline, 1 month, and 3 months

  3. Self-Compassion Measured by the Self-Compassion Scale (SCS-26)

    Self-compassion will be assessed using the 26-item Self-Compassion Scale (SCS-26), comprising six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. Items are rated on a five-point scale from 1 to 5. A total self-compassion score is calculated after reverse scoring negatively worded items, with higher scores indicating greater self-compassion.

    Measured: Baseline, 1 month, and 3 months

  4. Participation in Municipal Cancer Rehabilitation

    The proportion of participants who reported participation in municipal cancer rehabilitation services will be assessed at the three-month follow-up. Participation is defined as patient-reported engagement in a municipal cancer rehabilitation program during the follow-up period. The proportion of participants reporting rehabilitation participation will be compared between the two randomized groups.

    Measured: Within 3 months after the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2026
  2. Study start10 Oct 2023
  3. Primary completion4 Jan 2026
  4. Study completion4 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07876388
Sponsor's protocol ID
23/25778
Status last verified
Oct 2026
First submitted
9 Oct 2026
Last updated
15 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The datasets generated and analyzed during the current study are not publicly available due to privacy and data protection regulations. Data sharing is restricted by applicable Danish data protection legislation and institutional requirements.

Questions about this trial

What is this clinical trial studying?

A study testing Compassionate Access Targeted Therapy in people with Colonrectal Cancer and Colonrectal Cancer (CRC), run by Esbjerg Hospital - University Hospital of Southern Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Health-Related Quality of Life Measured by FACT-C Total Score (time frame: 3 months after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in